N-palmitoyl-ethanolamine (PEA) induces peripheral antinociceptive effect by ATP-sensitive K+-channel activation

Journal of Pharmacological Sciences

Volumn 118, Issue 2, 2012, Pages 156-160

  Romero, Thiago Roberto Lima ^a   Duarte, Igor Dimitri Gama ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cannabinoid agonist; N palmitoyl ethanolamine (PEA); Peripheral antinociception

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CANNABINOID 2 RECEPTOR AGONIST; DEQUALINIUM; GLIBENCLAMIDE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PALMIDROL; PAXILLINE; POTASSIUM CHANNEL; PROSTAGLANDIN E2; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NONHUMAN; PAIN THRESHOLD; PERIPHERAL ANTINOCICEPTION; RAT;

EID: 84857594321     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11150FP     Document Type: Article

References (35)

1. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, et al. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur J Pharmacol. 2009;613:54-59.
2. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 1998;394: 277-281. (Pubitemid 28335039)
3. Helyes Z, Németh J, Thán M, Bölcskei K, Pintér E, Szolcsányi J. Inhibitory effect of anandamide on resiniferatoxin- induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. Life Sci. 2003;73:2345-2353. (Pubitemid 36980829)
4. Re G, Barbero R, Miolo A, Di Marzo V. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet J. 2007;173:21-30.
5. Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain. 2008;139:541-550.
6. De Filippis D, D'Amico A, Cinelli MP, Esposito G, Di Marzo V, Iuvone T. Adelmidrol, a palmitoylethanolamide analog, reduces chronic inflammation in a carrageenin-granuloma model in rats. J Cell Mol Med. 2008;13:1086-1095.
7. Romero-Sandoval A, Eisenach JC. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiol. 2007;106:787-794. (Pubitemid 46555623)
8. Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, et al. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology. 2005;48:1154-1163. (Pubitemid 40725988)
9. Duarte IDG, Dos Santos IR, Lorenzetti BB, Ferreira SH. Analgesia by direct antagonism of nociceptor sensitization involves the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol. 1992;217:225-227.
10. + channels, and sodium nitroprusside and dibutyryl-cGMP. Eur J Pharmacol. 2004;489:59-65.
11. Romero TRL, Duarte IDG. á2 Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the Larginine/ nitric oxide/cyclic GMP pathway in rat. Eur J Pharmacol. 2009;613:64-67.
12. Thornbury KD, Ward SM, Dalziel HH, Carl A, Westfall DP, Sanders KM. Nitric oxide and nitrosocysteine mimic nonadrenergic, noncholinergic hyperpolarization in canine proximal colon. Am J Physiol. 1991;261:G553-G557.
13. 2+-activated K channels. Am J Physiol. 1997;273:H76-H84.
14. Soares AC, Leite R, Tatsuo MA, Duarte ID. Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol. 2000;400:67-71. (Pubitemid 30412110)
15. 2-induced hyperalgesic paw. Br J Pharmacol. 2001;134:127-131.
16. Moncada S, Radomski MW, Palmer RM. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol. 1988;37:2495-2501.
17. Knowles RG, Palacios M, Palmer RMJ, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A. 1989;86:5159-5162. (Pubitemid 19182253)
18. Romero TRL, Galdino GS, Silva GC, Resende LC, Perez AC, Cortes SF, et al. Involvement of the L-arginine/NO/cGMP pathway in peripheral N-palmitoyl-ethanolamine induced antinociception in rat. J Neurosci Res. In press.
19. Green AF, Young PA. A comparison of heat and pressure analgesiometric methods in rats. Br J Pharmacol. 1951;6:572-585.
20. Randall LO, Sellito JJ. A method for measurement of analgesic activity on inflamed tissues. Arch Int Pharmacodyn. 1957;111: 409-419.
21. +channels. Annu Rev Pharmacol Toxicol. 1993;33:597-637.
22. Cook NS, Quast U. Potassium channel pharmacology. In: Cook NS, editor. Potassium channels: structure, classification, function, and therapeutic potential. Chichester: Ellis Horwood; 1990. p. 181-225.
23. Dunn PM. Dequalinium, a selective blocker of the slow after-hyperpolarization in rat sympathetic neurons in culture. Eur J Pharmacol. 1994;252:189-194. (Pubitemid 24050997)
24. Li G, Cheung DW. Effects of paxilline on K+ channels in rat mesenteric arterial cells. Eur J Pharmacol. 1999;372:103-107. (Pubitemid 29229869)
25. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, et al. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther. 2006;319:1051-1061.
26. Ibrahin MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Ssi U S A. 2005;102:3093-3098. (Pubitemid 40299921)
27. Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S. Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury. J Pharmacol Sci. 2008;108:341-347.
28. Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972;240:200-203.
29. Duarte IDG, Lorenzetti BB, Ferreira SH. Acetylcholine induces peripheral analgesia by the release of nitric oxide. Eur J Pharmacol. 1990;186:289-293. (Pubitemid 20308253)
30. 2adrenoceptor agonist xylazine. J Pharmacol Sci. 2009;111:323-327.
31. Gillis KD, Gee WM, Hammoud A, McDaniel ML, Falke LC, Misler S. Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am J Physiol. 1989;257:1119-1127.
32. Barrett-Jolley R, Davies NW. Kinetic analysis of the inhibitory effect of glibenclamide on KATP channels of mammalian skeletal muscle. J Membr Biol. 1997;155:257-262. (Pubitemid 27117901)
33. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol. 1995;48:443-450.
34. Kleuss C, Scherübl H, Hescheler J, Schultz G, Wittig B. Different beta-subunits determine G-protein interaction with transmembrane receptors. Nature. 1992;358:424-426.
35. Reis GM, Ramos MA, Pacheco DD, Klein A, Perez AC, Duarte ID. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K(+) channels. Life Sci. 2011;88:653-657.